Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Agenus Designates Bap Pharma as the Exclusive Global Partner for Bot + Bal.

Summary by Hastings Tribune
LEXINGTON, Massachusetts (EE. UU.) & MARLOW, Inglaterra--(BUSINESS WIRE)--abr. 21, 2026-

4 Articles

Hastings TribuneHastings Tribune
Reposted by
Voice of AlexandriaVoice of Alexandria
Center

Agenus Appoints Bap Pharma as the Exclusive Global Partner for the Bot+bal Access Programs.

LEXINGTON, Massachusetts, e MARLOW, Inglaterra--(BUSINESS WIRE)--abr 21, 2026-

·Nebraska, United States
Read Full Article
The Daily NewsThe Daily News
Center

Agenus Appoints Bap Pharma as the Exclusive Global Partner for the Bot+bal Access Programs

LEXINGTON, Massachusetts, USA, and MARLOW, UK--(BUSINESS WIRE)--Apr 21, 2026-

Read Full Article
HealthTech HotSpotHealthTech HotSpot

Agenus Names BAP Pharma as Exclusive Global Partner for BOT+BAL Access Programs

Partnership enables timely access to botensilimab plus balstilimab through France’s government-reimbursed Autorisation d’Accès Compassionnel (AAC) pathway and paid named-patient programs (NPP) in select countries LEXINGTON, Mass. & MARLOW, England--(BUSINESS WIRE)--$AGEN #AAC--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, and BAP Pharma, a global medicines access and clinical trial supply company, today announced the exclus…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

HealthTech HotSpot broke the news on Tuesday, April 21, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Lexington, Massachusetts icon

Lexington, Massachusetts

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal